Kezar Life Sciences Announces Promising Data from First in Patient Study of KZR-616 at EULAR 2019 Annual Meeting

NEXT STORY
VBI Vaccines Announces Results of Annual General Meeting
PREV STORY
Inventiva announces the creation of its Scientific Advisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tiziana Life Sciences plc (“Tiziana” or the “Company”) – Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil

author_avatar
NASDAQ Market News

Global Orphan Drugs Market Analysis 2014-2019 & Forecasts 2020-2025 by Drug Type, Disease Type, Phase, Top Sellers, Distribution, Value Chain, Price, Competitive Landscape

author_avatar
NASDAQ Market News

Genmab Announces Late-Breaking Oral Presentation of Phase 2 innovaTV 204 Study at the ESMO Virtual Congress 2020

author_avatar
NASDAQ Market News